medicinal chemistry.

Members of our leadership team were responsible for 12 clinical candidates that advanced from hit to clinical trials. We know that the most successful projects come from high quality leads and unrelenting focus on DMPK and multi-parameter optimization.

Since 2012, lntelliSyn scientists were named as co-inventors on 16 of our clients’ projects and 3 clinical candidates are advancing in IND-enabling tox. Our areas of proven expertise include: